Clinical data have shown liraglutide to provide greater reductions in body weight compared with short- and long-acting exenatide, short-acting lixisenatide and long-acting dulaglutide, with markedly greater reductions vs
Protein sources can be both animal-based and plant-based
We dont recommend taking the first dose of an increased strength while away travelling, as this is a high-risk point for side effects, and we recommend starting a new dose strength once home or remaining on the same dose for an additional month if travelling for a significant period
A tailored treatment plan can determine each patients most appropriate session frequency
MASH resolved in patients treated with tirzepatide at one of three doses Launched in 2019, the SYNERGY-NASH trial evaluated tirzepatide in 196 overweight adults, ages 18-80, with biopsy-proven MASH and stage 2 or 3 liver fibrosis, reflecting moderate to significant fibrosis that hasnt progressed to cirrhosis
Liquid format offers convenience and ease of use